1
Sep 26, 2023
Initiating the provision of analysis information on differences in drug effects for each genetic polymorphism for contributing to the advancement of drug development and improvement in treatment options and treatment satisfaction for patients. 3H Medi Solution Inc. (Toshima-ku, Tokyo; CEO: Hirotaka Takizawa) and Genequest Inc. (Minato-ku, Tokyo; CEO: Osamu Iwata) have jointly conducted an analysis […]
2
May 31, 2022
The world is transitioning into the information age in healthcare and modern digital health technologies have a lot to offer in optimising clinical trial conduct. The advent of wearable medical devices has enabled collection of multi-dimensional subject data. This has enabled de-centralisation of clinical trial conduct. 3H has been agile to adopt the latest information […]
3
Apr 5, 2022
Ono Pharmaceutical Co., Ltd. (Osaka, Japan; Representative Director, President, Gyo Sagara; “ONO”) and 3H Clinical Trial Inc. (Tokyo, Japan; Representative Director, Hirotaka Takizawa; “3H”) announced that the companies developed and started providing “Fukusapo”, an adverse drug reaction (ADR) management supporting tool for patients as from today, aiming at the ADR management in patients receiving the […]
4
Mar 25, 2022
Clinical trial conduct is a substantial investment requiring the right mix of resources and time. With the pharmaceutical industry facing many challenges in the Western world due to escalating costs and challenges in meeting the recruitment and retention of subjects, there is a trend in navigating clinical trial options in the Asian continent. Contract research […]
5
Dec 14, 2021
Supporting clinical trial patients at home is getting popular choice today in Japan following this pandemic. The need for decentralized clinical trials in Japan has increased, as measures have been implemented to prevent the re-emergence of the outbreak and streamline the systems used to run clinical trials. Unless mandatory, clinical trial patients are served in […]
6
Oct 28, 2021
LOS ANGELES and TOKYO, October 27, 2021 — Science 37, the Operating System for today’s more agile clinical trials and 3H Medi Solution Inc., a clinical trials solution leader in Japan today announced a collaboration to further decentralized clinical trials and accelerate the development of therapies. In this partnership, 3H Medi Solution will use Science […]
7Oct 14, 2021
System integration between ePRO (electronic patient report outcome) and electronic medical record (EMR). Possibility to confirm data input from electronic medical record itself done on the cancer patient app. Improve the quality of medical care by utilizing ICT in line with the medical field. St. Marianna University School of Medicine (Kawasaki City, Kanagawa Prefecture, President: […]
8
Jul 1, 2021
South Korea has made a name in the clinical trial industry through its unprecedented growth in the industry during the past two decades. There has been several regulatory reforms, adoption of ICH-GCP and continuous investment by the government to enhance the standards and quality of clinical trial conduct to make the country a Global Centre […]
9
Jun 11, 2021
Medical care is undergoing rapid changes and the latest technology has provided solutions for the growing complex problems in aging care and other healthcare needs. With the pandemic taking a toll, it has added innovative care delivery methods for the nursing of patients from the comfort of homes moving beyond the traditional hospital beds where […]
10
May 19, 2021
The word ‘Cancer’ looms fear and anxiety in the minds of the general public. The insidious onset and the possible devastative outcome which this disease can bring about, makes it one of the most dreaded diseases by mankind. However today, this perception is slowly declining adding a ray of hope into the lives of cancer […]